New BMJ Study: Pharma-Backed Flu Vax Studies Get Special Treatment

[Turquesa]

http://www.nvic.org/Downloads/Jeffer...l-BMJ2009.aspx

The Cochrane Collaboration meta-analyzed various flu vax studies to find that those sponsored by Pharma were more likely to have favorable reviews (duh) and get published . . . regardless of the actual study quality.

This will come as no surprise to "frequent fliers" in the vax forum, but at least now you have some research confirming your suspicions.

[Sileree]

Barbara Loe Fisher talked about this on her blog today:

In a questionable "class action" type Omnibus hearing process, whereby the U.S. Department of Justice allowed (encouraged?) some 5,000 cases of regressive autism after vaccination to be lumped together and argued by plaintiff's lawyers using two narrow biological mechanism hypotheses involving thimerosal and MMR vaccine, the first three Omnibus cases were rejected by three special masters employed by the U.S. Court of Claims. The Court relied heavily on epidemiological studies published in medical journals - the same medical journals which give preferential treatment to methodologically flawed studies funded by vaccine manufacturers.

http://vaccineawakening.blogspot.com/